NO813065L - 2-(1,4-benzodioksan-2-ylalkyl)imidazoler og fremgangsmaate til deres fremstilling - Google Patents

2-(1,4-benzodioksan-2-ylalkyl)imidazoler og fremgangsmaate til deres fremstilling

Info

Publication number
NO813065L
NO813065L NO813065A NO813065A NO813065L NO 813065 L NO813065 L NO 813065L NO 813065 A NO813065 A NO 813065A NO 813065 A NO813065 A NO 813065A NO 813065 L NO813065 L NO 813065L
Authority
NO
Norway
Prior art keywords
benzodioxan
imidazole
hydrogen
acid
formula
Prior art date
Application number
NO813065A
Other languages
English (en)
Norwegian (no)
Inventor
Arthur F Kluge
Arthur M Strosberg
L David Waterbury
Roger L Whiting
George A Christie
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO813065L publication Critical patent/NO813065L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO813065A 1980-09-10 1981-09-09 2-(1,4-benzodioksan-2-ylalkyl)imidazoler og fremgangsmaate til deres fremstilling NO813065L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/185,832 US4302469A (en) 1980-09-10 1980-09-10 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants

Publications (1)

Publication Number Publication Date
NO813065L true NO813065L (no) 1982-03-11

Family

ID=22682624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813065A NO813065L (no) 1980-09-10 1981-09-09 2-(1,4-benzodioksan-2-ylalkyl)imidazoler og fremgangsmaate til deres fremstilling

Country Status (17)

Country Link
US (1) US4302469A (da)
EP (1) EP0047531B1 (da)
JP (1) JPS5750989A (da)
KR (1) KR830007626A (da)
AT (1) ATE13765T1 (da)
AU (1) AU541413B2 (da)
CA (1) CA1173044A (da)
DE (1) DE3170937D1 (da)
DK (1) DK400781A (da)
ES (1) ES8205791A1 (da)
FI (1) FI812804L (da)
HU (1) HU186781B (da)
IL (1) IL63782A (da)
NO (1) NO813065L (da)
NZ (1) NZ198321A (da)
YU (1) YU217181A (da)
ZA (1) ZA816259B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
US4402967A (en) * 1981-04-23 1983-09-06 Syntex (U.S.A.) Inc. Method for lowering intraocular pressure
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
FI833224L (fi) * 1983-09-09 1985-03-10 Farmos Oy Foerfarande foer framstaellning av ett terapeutiskt aktivt aemne.
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4943311A (en) * 1988-05-09 1990-07-24 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
IL95760A0 (en) * 1989-09-27 1992-05-25 Rhone Poulenc Sante Imidazole derivatives,their preparation and pharmaceutical compositions containing the same
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
AU2004281750A1 (en) * 2003-10-14 2005-04-28 Wyeth Use of adrenergic alphaze antagonists for the treatment of vasomotor symptoms

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA731147A (en) 1966-03-29 Charles E. Frosst And Co. 1:4 benzodioxan derivatives
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
US3360529A (en) * 1962-01-29 1967-12-26 Smith Kline French Lab Guanidinoalkylbenzodioxan derivatives
GB1094982A (en) 1963-05-08 1967-12-13 Ward Blenkinsop & Co Ltd 1,4-benzodioxanes
BE643853A (da) 1964-02-20 1964-08-14
US3829411A (en) * 1972-03-29 1974-08-13 Eastman Kodak Co Thiadiazolyl-azo-indole compounds
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GB1457038A (en) * 1973-10-23 1976-12-01 Lafon Labor Amino derivatives of 1,4-benzodioxan
GB1520801A (en) 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans

Also Published As

Publication number Publication date
CA1173044A (en) 1984-08-21
EP0047531A1 (en) 1982-03-17
HU186781B (en) 1985-09-30
ES505329A0 (es) 1982-08-16
FI812804A7 (fi) 1982-03-11
ZA816259B (en) 1983-04-27
ES8205791A1 (es) 1982-08-16
IL63782A0 (en) 1981-12-31
NZ198321A (en) 1985-07-12
KR830007626A (ko) 1983-11-04
US4302469A (en) 1981-11-24
AU541413B2 (en) 1985-01-10
DK400781A (da) 1982-03-11
ATE13765T1 (de) 1985-06-15
AU7509481A (en) 1982-03-18
YU217181A (en) 1983-10-31
EP0047531B1 (en) 1985-06-12
FI812804L (fi) 1982-03-11
DE3170937D1 (en) 1985-07-18
IL63782A (en) 1984-03-30
JPS5750989A (en) 1982-03-25

Similar Documents

Publication Publication Date Title
KR100258052B1 (ko) 5ht2c-수용체 길항제로서의 피리미딘 유도체 및 이를 포함하는 약물
RU2235092C2 (ru) Замещенные производные имидазола, способ введения активного соединения и способ лечения на основе этих соединений
DE69013601T2 (de) Heteroaryl Piperazine als antipsychotische Mittel.
NO813065L (no) 2-(1,4-benzodioksan-2-ylalkyl)imidazoler og fremgangsmaate til deres fremstilling
CA1156241A (en) Imidazoline derivative
US4675403A (en) 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4411908A (en) Imidazoline derivatives as presynaptic α2 -adrenoreceptor antagonists
US4732984A (en) Piperazinoisothiazolones with psychotropic activity
EP0964863B1 (de) Oxazolidinone als 5-ht2a-antagonisten
EP0529654A1 (en) Benzopyran derivatives as potassium channel activators and 5-lipoxygenase inhibitors
DE69109132T2 (de) Indanderivate.
US4397860A (en) Benzodioxanyl imidazoline compounds, compositions and use
US4405622A (en) [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
US4315021A (en) 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4436914A (en) Benzodioxane-imidazoline compounds as antihypertensives
NO167389B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive diazinylpiperidinderivater av cykliske amider og imider.
EP0638568B1 (fr) Pipérazines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant
BG64871B1 (bg) Трициклични делта 3-пиперидини, като лекарства
EP1192152B1 (fr) Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
HU190894B (en) Process for preparing imidazoline derivatives
US4709027A (en) Bicyclic spirosulfonimides with psychotropic activity
US4497818A (en) 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antihypertensives and platelet aggregation inhibitors
IE52074B1 (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles,their preparation and pharmaceutical compositions containing them
DE69320542T2 (de) Pyrrolothienopyrazin-Verbindungen als 5HT3-Rezeptoren-Antagonisten
NZ236231A (en) Thio substituted piperidine derivatives and pharmaceutical compositions